Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11801 | 30735525 | PLoS One | Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice. | 2019 | Details |
| A11803 | 30734333 | Hepatology | Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2019 | Details |
| A11810 | 30729549 | Hepatology | Reply. | 2019 | Details |
| A11835 | 30714632 | Aliment Pharmacol Ther | Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside. | 2019 | Details |
| A11852 | 30708071 | Diabetes Metab | Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications. | 2019 | Details |
| A11856 | 30707092 | Nutr Res Rev | Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. | 2019 | Details |
| A11867 | 30703836 | Dtsch Med Wochenschr | [The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]. | 2019 | Details |
| A11882 | 30697898 | Liver Int | The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States. | 2019 | Details |
| A11884 | 30697502 | Cureus | Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A11890 | 30692925 | Front Pharmacol | Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues. | 2019 | Details |
| A11901 | 30687994 | Diabetes Obes Metab | Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2019 | Details |
| A11907 | 30685917 | Zhonghua Gan Zang Bing Za Zhi | [Prevalence and harm of nonalcoholic fatty liver disease]. | 2019 | Details |
| A11908 | 30685742 | J Pediatr Endocrinol Metab | Hepatopathies in children and adolescents with type 1 diabetes. | 2019 | Details |
| A11911 | 30684076 | Dig Dis Sci | Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. | 2019 | Details |
| A11916 | 30683312 | Biochem Biophys Res Commun | Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway. | 2019 | Details |
| A11927 | 30679317 | Oncologist | Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study. | 2019 | Details |
| A11930 | 30677224 | Mol Nutr Food Res | Beneficial Effects of Pomegranate on Lipid Metabolism in Metabolic Disorders. | 2019 | Details |
| A11938 | 30673802 | Diabetologia | The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes. | 2019 | Details |
| A11951 | 30670819 | Nat Rev Endocrinol | Gut microbial metabolites in obesity, NAFLD and T2DM. | 2019 | Details |
| A11969 | 30663219 | Liver Int | Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. | 2019 | Details |
| A11985 | 30658440 | Int J Mol Sci | Interactions between Host PPARs and Gut Microbiota in Health and Disease. | 2019 | Details |
| A11987 | 30657626 | Liver Int | Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis. | 2019 | Details |
| A11990 | 30655210 | Hipertens Riesgo Vasc | [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population]. | 2019 | Details |
| A11996 | 30653387 | J Womens Health (Larchmt) | Serum Testosterone Level Within Normal Range Is Positively Associated with Nonalcoholic Fatty Liver Disease in Premenopausal but Not Postmenopausal Women. | 2019 | Details |
| A11998 | 30652643 | Curr Pharm Des | The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12006 | 30648978 | Holist Nurs Pract | Traditional Chinese Medicine and Intestinal Microbiota: A Complementary and Integrative Health Approach to Ameliorate Obesity-Related Diseases. | 2020 | Details |
| A12011 | 30645665 | Internist (Berl) | [New aspects of nonalcoholic steatohepatitis]. | 2019 | Details |
| A12020 | 30641706 | Diabetes Metab Syndr | Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study. | 2018 | Details |
| A12023 | 30639779 | Clin Gastroenterol Hepatol | Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2019 | Details |
| A12033 | 30631885 | Singapore Med J | A practical clinical approach to liver fibrosis. | 2018 | Details |
| A12048 | 30625285 | Annu Rev Pharmacol Toxicol | Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes. | 2019 | Details |
| A12054 | 30621686 | Lipids Health Dis | Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice. | 2019 | Details |
| A12084 | 30609189 | Liver Transpl | Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. | 2019 | Details |
| A12088 | 30607652 | Clin Rheumatol | Prevalence and risk factors associated with hyperuricemia among working population at high altitudes: a cross-sectional study in Western China. | 2019 | Details |
| A12090 | 30606928 | Yakugaku Zasshi | [The Investigation of Genes, Using an Improved Adenovirus Vector, and Food for the Treatment and Prevention of Type 2 Diabetes Mellitus]. | 2019 | Details |
| A12102 | 30601337 | Eur J Gastroenterol Hepatol | Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2019 | Details |
| A12104 | 30600551 | J Gastroenterol Hepatol | HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease. | 2019 | Details |
| A12111 | 30597715 | Liver Int | Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. | 2019 | Details |
| A12121 | 30594638 | Biochim Biophys Acta Gene Regul Mech | Role of long non-coding RNAs in metabolic control. | 2018 | Details |
| A12124 | 30592792 | J Diabetes Investig | Insulin-like growth factor-1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus. | 2019 | Details |
| A12127 | 30590942 | Vnitr Lek | Fatty pancreas disease: clinical impact. | 2019 | Details |
| A12135 | 30588564 | Drugs | Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A12139 | 30586008 | J Clin Gastroenterol | Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A12154 | 30580090 | Clin Gastroenterol Hepatol | Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation. | 2018 | Details |
| A12164 | 30577089 | Hepatol Res | Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus. | 2019 | Details |
| A12180 | 30573307 | Nutr Metab Cardiovasc Dis | High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. | 2018 | Details |
| A12190 | 30568471 | Diabetes Metab Syndr Obes | Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis. | 2018 | Details |
| A12220 | 30557902 | Diabetes Metab Res Rev | Apolipoprotein CIII and diabetes. Is there a link? | 2019 | Details |
| A12231 | 30554783 | Lancet | Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial. | 2018 | Details |
| A12234 | 30553186 | Micron | Primary cultured neuronal networks and type 2 diabetes model mouse fatty liver tissues in aqueous liquid observed by atmospheric SEM (ASEM): Staining preferences of metal solutions. | 2018 | Details |
| A12241 | 30551370 | Biomed Pharmacother | Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes. | 2018 | Details |
| A12242 | 30551263 | J Gastroenterol Hepatol | Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. | 2019 | Details |
| A12248 | 30547890 | Eur Cytokine Netw | Obesity and inflammation. | 2018 | Details |
| A12285 | 30533179 | World J Hepatol | Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? | 2018 | Details |
| A12296 | 30521580 | PLoS One | E4orf1: A protein for enhancing glucose uptake despite impaired proximal insulin signaling. | 2018 | Details |
| A12297 | 30520566 | Obesity (Silver Spring) | Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study. | 2018 | Details |
| A12300 | 30519965 | Acta Diabetol | A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? | 2018 | Details |
| A12334 | 30510994 | Cell Mol Gastroenterol Hepatol | Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice. | 2018 | Details |
| A12344 | 30498904 | J Gastroenterol | A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update. | 2018 | Details |
| A12350 | 30495974 | Am J Physiol Gastrointest Liver Physiol | Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. | 2018 | Details |
| A12366 | 30483595 | JGH Open | Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. | 2018 | Details |
| A12379 | 30477455 | BMC Endocr Disord | Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial. | 2018 | Details |
| A12386 | 30473540 | Biosci Rep | Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. | 2018 | Details |
| A12390 | 30473057 | Metabolism | Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. | 2018 | Details |
| A12392 | 30472977 | J Pharm Pharm Sci | Non-alcoholic Steatohepatitis (NASH) Drug Discovery - Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development. | 2018 | Details |
| A12398 | 30472196 | Diabetes Metab | Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes. | 2018 | Details |
| A12401 | 30470912 | Diabetologia | Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. | 2018 | Details |
| A12407 | 30467936 | Pediatr Diabetes | Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects. | 2018 | Details |
| A12420 | 30461221 | J Diabetes Investig | Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A12421 | 30460863 | Pharm Biol | Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus. | 2018 | Details |
| A12424 | 30459251 | Diabetes | Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12429 | 30458246 | Clin Gastroenterol Hepatol | Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults With Type 2 Diabetes. | 2018 | Details |
| A12434 | 30456918 | Diabetes Obes Metab | Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis? | 2018 | Details |
| A12436 | 30455585 | Contemp Oncol (Pozn) | Update in global trends and aetiology of hepatocellular carcinoma. | 2018 | Details |
| A12438 | 30455362 | J Lipid Res | Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol. | 2018 | Details |
| A12448 | 30453753 | Ann Clin Biochem | Bile acids and the metabolic syndrome. | 2019 | Details |
| A12454 | 30448600 | Clin Gastroenterol Hepatol | Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis. | 2018 | Details |
| A12457 | 30447037 | Diabetes Obes Metab | Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes. | 2018 | Details |
| A12463 | 30445758 | Children (Basel) | Extracellular Vesicles: A Potential Novel Regulator of Obesity and Its Associated Complications. | 2018 | Details |
| A12467 | 30444204 | Endocr Metab Immune Disord Drug Targets | Diabetes Association with Liver Diseases: An Overview for Clinicians. | 2019 | Details |
| A12471 | 30441981 | Vnitr Lek | Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms. | 2019 | Details |
| A12474 | 30431378 | Curr Med Res Opin | Severe nonalcoholic steatohepatitis and type 2 diabetes: liver histology after weight loss therapy in a randomized clinical trial. | 2018 | Details |
| A12478 | 30430519 | Tunis Med | Estimation of the prevalence of obstructive sleep apnea in non alcoholic fatty liver disease. | 2018 | Details |
| A12487 | 30428692 | Diab Vasc Dis Res | Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2018 | Details |
| A12489 | 30427105 | Liver Int | Metabolic factors affecting hepatocellular carcinoma in steatohepatitis. | 2018 | Details |
| A12495 | 30423871 | Int J Environ Res Public Health | Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia. | 2018 | Details |
| A12499 | 30420265 | Arab J Gastroenterol | Managing diabetes and liver disease association. | 2018 | Details |
| A12505 | 30415572 | Orv Hetil | [Non-alcoholic fatty liver disease - a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016]. | 2018 | Details |
| A12510 | 30414863 | J Hepatol | Non-alcoholic fatty liver disease - A global public health perspective. | 2018 | Details |
| A12513 | 30413815 | Lab Invest | Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero. | 2018 | Details |
| A12514 | 30413050 | Pharmaceuticals (Basel) | Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once? | 2018 | Details |
| A12519 | 30411703 | Turk J Gastroenterol | Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study. | 2019 | Details |
| A12525 | 30411081 | Hepatol Commun | Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12543 | 30400829 | BMC Gastroenterol | Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan. | 2018 | Details |
| A12551 | 30394863 | Metab Syndr Relat Disord | Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers. | 2018 | Details |
| A12554 | 30393477 | Arch Med Sci | Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis. | 2017 | Details |
| A12555 | 30393249 | Endocr J | Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: a subgroup analysis of the STELLA-LONG TERM study (3-month interim results). | 2018 | Details |
| A12574 | 30384370 | Nephron | Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12582 | 30378562 | Biomed Khim | [Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity]. | 2018 | Details |
| A12589 | 30374109 | Sci Rep | Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism. | 2018 | Details |